First, we investigated whether the correlation of miR-145 and FSCN1 could be clinically relevant by measuring the expression of miR-145 and FSCN1 mRNA/protein levels in normal/tumor paired samples from 80 patients with gastric cancer. Here, FSCN1 is linked to gastric cancer.